New diabetes pill tested for blood sugar control
NCT ID NCT00628212
Summary
This study tested a new diabetes medication called Teneligliptin (MP-513) to see if it safely lowers blood sugar levels in Japanese adults with type 2 diabetes. Over 300 participants took either the drug or a placebo pill daily for 12 weeks. The main goal was to measure changes in a key blood sugar marker (HbA1c) and gather safety data to help plan a larger, final-stage trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Takikawa-shi, Hokkaido, Japan
Conditions
Explore the condition pages connected to this study.